Literature DB >> 16364542

Acute limbic encephalitis: a new entity?

Yoko Mochizuki1, Toshio Mizutani, Eiji Isozaki, Toshiyuki Ohtake, Yukitoshi Takahashi.   

Abstract

Clinical cases similar to herpes simplex virus (HSV) encephalitis have accumulated in Japan. Detailed examinations have failed to demonstrate HSV infection. Recently, these cases have been named "non-herpetic acute limbic encephalitis". Only a single autopsy case was so far reported in an abstract form, because many cases showed a good prognosis. The case presented here was that following fever, a 59-year-old woman developed disturbance of consciousness and uncontrollable generalized seizures. Brain MRI revealed abnormal signals in the bilateral medial temporal lobe and along the lateral part of the putamen. Autoantibody against the NMDA glutamate receptor (GluR) IgM-epsilon2 was detected in the serum, and the GluR IgG-delta2 antibody was positive in cerebrospinal fluid. She died 12 days after onset. An autopsy examination revealed scattered foci consisting of neuronal loss, neuronophagia and some perivascular lymphocytic infiltration in the hippocampus and amygdala, but no haemorrhagic necrosis in the brain. HSV-1, -2 and human herpes virus-6 were negative immunohistochemically. We believe that our autopsy case may contribute to understanding the neuropathological background of non-herpetic acute limbic encephalitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16364542     DOI: 10.1016/j.neulet.2005.08.070

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes.

Authors:  L Bataller; K A Kleopa; G F Wu; J E Rossi; M R Rosenfeld; J Dalmau
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-15       Impact factor: 10.154

Review 2.  Neuropsychological symptoms in paraneoplastic disorders.

Authors:  Raymond Voltz
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

3.  Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Neuropsychiatric and Multidisciplinary Approach to a Patient Not Responding to First-Line Treatment.

Authors:  Arsen S Askandaryan; Abbas Naqvi; Amanda Varughese; Dina Rimawi
Journal:  Cureus       Date:  2022-06-08

4.  A patient with encephalitis associated with NMDA receptor antibodies.

Authors:  Lauren H Sansing; Erdem Tüzün; Melissa W Ko; Jennifer Baccon; David R Lynch; Josep Dalmau
Journal:  Nat Clin Pract Neurol       Date:  2007-05

Review 5.  Diagnostic and pathogenic significance of glutamate receptor autoantibodies.

Authors:  David Pleasure
Journal:  Arch Neurol       Date:  2008-05

6.  Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in non-herpetic acute limbic encephalitis.

Authors:  Takashi Ichiyama; Yukitoshi Takahashi; Takeshi Matsushige; Madoka Kajimoto; Shinnosuke Fukunaga; Susumu Furukawa
Journal:  J Neurol       Date:  2009-08-12       Impact factor: 4.849

7.  PET/CT in the evaluation of anti-NMDA-receptor encephalitis: What we need to know as a NM physician.

Authors:  S Padma; P Shanmuga Sundaram; Bobby Varkey Marmattom
Journal:  Indian J Nucl Med       Date:  2011-04

Review 8.  Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment.

Authors:  Helen Barry; Susan Byrne; Elizabeth Barrett; Kieran C Murphy; David R Cotter
Journal:  BJPsych Bull       Date:  2015-02

Review 9.  'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

10.  Analysis of a child who developed abnormal neuropsychiatric symptoms after administration of oseltamivir: a case report.

Authors:  Kaori Morimoto; Kei Nagaoka; Akira Nagai; Hirofumi Kashii; Masakiyo Hosokawa; Yukitoshi Takahashi; Takuo Ogihara; Masaya Kubota
Journal:  BMC Neurol       Date:  2015-08-05       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.